Key Results of International Randomized Open-Label Clinical Study of BCD-020 (rituximab biosimilar candidate) in Patients with B-Cell Non-Hodgkin’s Lymphoma
Autor: | Kaplanov, Kamil *, Zaritskiy, Andrey *, Alexeev, Sergey *, Volodicheva, Elena *, Loginov, Alexander *, Orlova, Rashida *, Dvornichenko, Victoria *, Kosinova, Marina *, Serduk, Olga *, Milovanov, Vladimir *, Myasnikov, Alexander *, Patil, Shekar *, Rangarajan, Bharath *, Rajappa, Senthil Jagannathan *, Jain, Minish *, Nirni, Sharanabasappa *, Deka, Akhil *, Rekhtman, Grigoriy B *, Kryachok, Iryna, Maslyak, Zvenyslava *, Chernyaeva, Ekaterina *, Ivanov, Roman *, Isaev, Alexander * |
---|---|
Zdroj: | In Blood 6 December 2014 124(21):5467-5467 |
Databáze: | ScienceDirect |
Externí odkaz: |